Clinical Trial Update: Plasma Marine n-3 Polyunsaturated Fatty Acids and Patient and Graft Survival

View source ↗

Summary

Clinical trial results evaluate plasma marine omega-3 fatty acids in kidney transplant recipients and their effect on patient and graft survival.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Transplanted Kidney

Drugs mentioned

• Marine n-3 polyunsaturated fatty acids (omega-3 fatty acids (EPA/DHA))

Snippet

Sponsor: Oslo University Hospital | Conditions: Disorder of Transplanted Kidney | Status: COMPLETED